Parvin Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$881K Buy
3,470
+200
+6% +$46.6K 0.69% 54
2026
Q1
$799K Hold
3,270
0.58% 57
2025
Q4
$677K Sell
3,270
-735
-18% -$145K 0.54% 65
2025
Q3
$743K Sell
4,005
-700
-15% -$120K 0.65% 52
2025
Q2
$719K Hold
4,705
0.72% 50
2025
Q1
$780K Buy
4,705
+35
+0.7% +$5.48K 0.86% 39
2024
Q4
$675K Buy
+4,670
New +$724K 0.71% 46

Other funds holding JNJ

Parvin Asset Management's JNJ Position: Q2 2026 in Review

Parvin Asset Management increased its Johnson & Johnson (JNJ) stake by 6.1% in Q2 2026, buying an estimated $46.6K and bringing the position to 3,470 shares worth $881K. The position accounts for 0.69% of the portfolio, ranked #54.

Parvin Asset Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Parvin Asset Management held 3,470 shares of Johnson & Johnson worth $881K as of Q2 2026.
  • Parvin Asset Management bought 200 Johnson & Johnson shares in Q2 2026, an estimated $46.6K.
  • Johnson & Johnson made up 0.69% of Parvin Asset Management's portfolio in Q2 2026, its #54 holding.
  • Parvin Asset Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.